Mayo Clinic research supports targeted therapy to manage kidney complications, potentially enabling continuation of lifesaving immunotherapy
April 22, 2026
April 22, 2026
ROCHESTER, Minnesota, April 22 [Category: BizHospital] -- The Mayo Clinic issued the following news release:
* * *
Mayo Clinic research supports targeted therapy to manage kidney complications, potentially enabling continuation of lifesaving immunotherapy
*
ROCHESTER, Minn. -Immune checkpoint inhibitors (ICIs) have transformed treatment for many types of cancer. In some patients, however, ICIs are associated with immune-related complications th . . .
* * *
Mayo Clinic research supports targeted therapy to manage kidney complications, potentially enabling continuation of lifesaving immunotherapy
*
ROCHESTER, Minn. -Immune checkpoint inhibitors (ICIs) have transformed treatment for many types of cancer. In some patients, however, ICIs are associated with immune-related complications th . . .